… prevention of cardiovascular diseases. Demographic trends and globalization lend immediacy
to the challenge of primary prevention of cardiovascular … foundation for cardiovascular risk …

… and clinical role of the n−6/n−3 ratio as a potential risk factor in cardiovascular diseases is …
of n−3 in the secondary prevention of sudden cardiac death due to arrhythmias, but suggests …

… glucose control have important clinical implications because they are associated with a
decrease in cardiovascular diseases. In addition, recent experimental and clinical studies have …

… prevention — both primary and secondary — are reviewed in depth. Clinical trials aimed at
primary and secondary prevention of … factor levels and in reducing clinical CVD events. More …

… supports fetal cardiovascular remodeling in FGR; we will discuss potential pathways for its
association with clinical CVDs in adults, and the potential implications for preventive public …

… and cardiovascular effects of weight loss and provide clinicians with appropriate treatment
guidelines for weight management in patients with obesity and cardiovascular disease. …

… European guidelines on cardiovascular prevention in clinical practice were first published
in 1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

… The findings reported here indicate that the measurement of EVA can easily be implemented
in clinical practice and be applied to cardiovascular prevention, in other words that EVA is …

Defining new approaches for the prevention and treatment of atherosclerosis is an important
priority. Recently, measurement of endothelial function in patients has emerged as a useful …

… Because of the public health implications of these data, a large-scale statin prevention trial
of 15 000 patents is scheduled to begin in early 2003 specifically targeting those with native …